BioNTech, Pfizer say they expect to have COVID-19 vaccine data for young children this quarterMarket Watch • 04/27/22
BioNTech, Pfizer seek FDA authorization of a COVID-19 booster for young childrenMarket Watch • 04/27/22
Pfizer and Biohaven's VYDURA® (Rimegepant) Granted First Ever Marketing Authorization by European Commission for Both Acute Treatment of Migraine and Prophylaxis of Episodic MigraineBusiness Wire • 04/27/22
Pfizer, Valneva plan to move Lyme disease vaccine candidate into Phase 3 trialMarket Watch • 04/26/22
Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine CandidateBusiness Wire • 04/26/22
WHO Endorses Pfizer's Antiviral Pill Paxlovid For High-Risk Covid Patients But Says Benefits ‘Trivial' For Low-Risk GroupsForbes • 04/21/22
Pfizer Invites Shareholders to Attend Virtual-Only 2022 Annual Meeting of Shareholders on April 28Business Wire • 04/19/22
Pfizer (PFE), BioNTech (BNTX) COVID Booster Effective in Young KidsZacks Investment Research • 04/18/22
Pfizer/BioNTech Fourth COVID-19 Vaccine Dose Protects Against Omicron For At Least One MonthBenzinga • 04/18/22